Recent insider trading activity from Behrenbruch Christian, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 28, 2026 | Telix Pharmaceuticals Ltd | $TLX | Behrenbruch Christian | MD & Group CEO | P | Ordinary Shares | 34500 | $14.48 | 20,709,500.0000 | 338,777,049 | 0.17% | 0.01% |
| April 29, 2026 | Telix Pharmaceuticals Ltd | $TLX | Behrenbruch Christian | MD & Group CEO | P | Ordinary Shares | 33435 | $14.87 | 20,742,935.0000 | 338,777,049 | 0.16% | 0.01% |